Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.16 USD | -3.49% | -2.80% | -23.43% |
Apr. 25 | Top Premarket Gainers | MT |
Apr. 25 | North American Morning Briefing : More Tech -2- | DJ |
Financials (USD)
Sales 2024 * | 24.07M | Sales 2025 * | 42.86M | Capitalization | 55.47M |
---|---|---|---|---|---|
Net income 2024 * | -61M | Net income 2025 * | -40M | EV / Sales 2024 * | 2.3 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 1.29 x |
P/E ratio 2024 * |
-0.94
x | P/E ratio 2025 * |
-2.22
x | Employees | 69 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 92.66% |
Latest transcript on Cidara Therapeutics, Inc.
1 day | -3.49% | ||
1 week | -2.80% | ||
Current month | +1.50% | ||
1 month | -33.92% | ||
3 months | -16.48% | ||
6 months | -21.04% | ||
Current year | -23.43% |
Managers | Title | Age | Since |
---|---|---|---|
Jeffrey Stein
CEO | Chief Executive Officer | 69 | 13-12-31 |
Preetam Shah
DFI | Director of Finance/CFO | 51 | 21-08-31 |
Les Tari
CTO | Chief Tech/Sci/R&D Officer | 57 | 12-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Daniel Burgess
CHM | Chairman | 62 | 14-03-31 |
Director/Board Member | 69 | 14-03-31 | |
Jeffrey Stein
CEO | Chief Executive Officer | 69 | 13-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 12.16 | -3.49% | 30,353 |
24-05-09 | 12.6 | -3.45% | 27,810 |
24-05-08 | 13.05 | -2.90% | 17,270 |
24-05-07 | 13.44 | -1.25% | 40,727 |
24-05-06 | 13.61 | +8.79% | 102,155 |
Delayed Quote Nasdaq, May 10, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-23.43% | 55.47M | |
+3.91% | 109B | |
+10.87% | 105B | |
+1.28% | 22.25B | |
-13.14% | 22.09B | |
-7.05% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |
- Stock Market
- Equities
- CDTX Stock